Beginning in August 2013, the Federal Open Payments Law (also known as the Physician Payment Sunshine Act) requires pharmaceutical and medical device/supply companies to report to Centers for Medicare & Medicaid Services both direct and indirect transfers of value to certain providers and teaching hospitals. See the University Compliance Office Open Payments Law Fact Sheet for guidance and more information on this important federal law.